US COVID cases could reach 20 million by January’s end

The number of confirmed COVID-19 cases in the US will likely nearly double to 20 million by the end of January, a new model predicts.

Sara Savat-WUSTL • futurity
Nov. 23, 2020 ~5 min

covid-19 viruses united-states health-and-medicine

Nipah virus may teach us about COVID-19 spread

Nipah virus, a disease with no vaccine, no cure, and a mortality rate of up to 70%, can teach us a lot about dealing with COVID-19, says Stephen Luby.

Rob Jordan-Stanford • futurity
Nov. 23, 2020 ~7 min

covid-19 viruses bats health-and-medicine immune-systems

Decoy could halt this deadly (and spreading) virus

More viral outbreaks are likely. Researchers are working to thwart one, Venezuelan equine encephalitus virus, with a decoy molecule.

Tamara Bhandari-Washington University • futurity
Nov. 20, 2020 ~7 min

brains viruses drug-development health-and-medicine

Experts: 2 COVID-19 vaccines bring us into ‘new territory’

Pfizer and Moderna announced they have developed effective coronavirus vaccines, but how will they work? Two experts weigh in.

Kat McAlpine-Boston • futurity
Nov. 20, 2020 ~10 min

covid-19 vaccines viruses health-and-medicine

Vibrations of coronavirus proteins may play a role in infection

Study suggests mechanical properties of spike proteins can predict infectivity and lethality of different coronaviruses.

David L. Chandler | MIT News Office • mit
Nov. 19, 2020 ~8 min

machine-learning medicine artificial-intelligence covid-19 biology pandemic health-care disease viruses research school-of-engineering civil-and-environmental-engineering national-institutes-of-health-nih mit-ibm-watson-ai-lab

New shingles vaccine may protect lymphoma patients

A new shingles vaccine may work where others have failed for patients with lymphoma, researchers report.

Leslie Orr-Rochester • futurity
Nov. 18, 2020 ~4 min

cancer vaccines viruses featured health-and-medicine immune-systems lymphoma

No, soaring COVID-19 cases are not due to more testing – they show a surging pandemic

COVID-19 cases are skyrocketing across the US. Testing has ramped up over the past few months, but increasing hospitalizations, deaths and test-positivity rates show that the virus is out of control.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Nov. 18, 2020 ~6 min

covid-19 coronavirus sars-cov-2 testing viruses world-health-organization-who infections deaths death-rate community-spread

What monoclonal antibodies are – and why we need them as well as a vaccine

Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?

Rodney E. Rohde, Professor Clinical Laboratory Science, Texas State University • conversation
Nov. 16, 2020 ~9 min

 covid-19  pandemic  sars-cov-2  remdesivir  viruses  antibody  steroids  monoclonal-antibodies  convalescent-plasma  dexamethasone

Ingredients in flu vaccine won't hurt you – two pharmacists explain why

Many people object to the added ingredients in vaccines. But pharmacists explain why those fears are unwarranted.

Anne P. Kim, Clinical assistant professor, Washington State University • conversation
Nov. 13, 2020 ~9 min

influenza autism fda flu anti-vaccination viruses immune-response anti-vaxxers flu-vaccine

How to host a safe holiday meal during coronavirus – an epidemiologist explains her personal plans

COVID-19 and holiday family gatherings are not a good pair. But taking the right precautions before, during and after the family gets together can greatly reduce coronavirus risk this holiday season.

Melissa Hawkins, Professor of Public Health, Director of Public Health Scholars Program, American University • conversation
Nov. 10, 2020 ~7 min

health covid-19 coronavirus pandemic transmission cooking holidays travel viruses christmas family thanksgiving ventilation fauci